Tina Dudney, MD
Pulmonary Disease · Knoxville, TNNPI 1285641746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,171 and has fallen 90.6% since, to $110 in 2025. That places this record below the midpoint for pulmonary disease clinicians in TN, where the typical reported total is $3,628.
Across 218 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$521
- GSK$391
- AstraZeneca$360
- Merck$343
- Insmed, Inc.$333
- Boehringer Ingelheim$323
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,75997%
- Education$1143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 39 | $521 |
| GSK | 27 | $391 |
| AstraZeneca(2 entities) | 14 | $360 |
| Merck | 17 | $343 |
| Insmed, Inc. | 17 | $333 |
| Boehringer Ingelheim | 17 | $323 |
| Jazz Pharmaceuticals Inc. | 11 | $274 |
| AbbVie(2 entities) | 16 | $269 |
| Genentech USA, Inc. | 10 | $166 |
| Grifols USA, LLC | 9 | $150 |
| Mylan Specialty L.p. | 8 | $121 |
| Johnson & Johnson | 4 | $64 |
| United Therapeutics Corporation | 3 | $59 |
| Novartis | 3 | $49 |
| Philips North America LLC | 2 | $47 |
| Pfizer | 3 | $41 |
| Sanofi | 2 | $41 |
| Baxter Healthcare | 2 | $38 |
| Vapotherm Inc | 2 | $38 |
| Harmony Biosciences LLC | 1 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Electromed, Inc. | 1 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Shionogi Inc | 1 | $18 |
| Resmed Corp | 1 | $17 |
| ZOLL Circulation Inc | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Gilead | 1 | $15 |
| Ambu Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,873 in reported general payments places this provider in the 50th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Knoxville
- John SwisherKnoxville$234K
- John PrinceKnoxville$117K
- Rajiv DhandKnoxville$96K
- Varun ShahKnoxville$64K
- Benjamin BevillKnoxville$31K
- Shannon ByrdKnoxville$23K
- James PharaohKnoxville$20K
- Isaac BineyKnoxville$16K
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.